Professor Sagnik Bhattacharyya, a leading authority in Translational Neuroscience and Psychiatry, directs pioneering research at the intersection of psychotic and substance abuse disorders, notably cannabis-related phenomena. Heading the Translational Neuroscience and Psychiatry research group, he orchestrates multi-center clinical trials investigating cannabidiol’s efficacy in psychosis and Parkinson’s disease psychosis.

With qualifications from Calcutta Medical College and extensive psychiatric training, Professor Bhattacharyya holds a distinguished position as a Consultant Psychiatrist at South London & Maudsley NHS Foundation Trust. His research, spanning diverse methodologies from neuroimaging to epidemiological cohort studies, aims to unravel the neurobiological underpinnings of cannabis use and its therapeutic potential.

Recognized with prestigious awards including the NIHR Clinician Scientist award, Professor Bhattacharyya is committed to bridging research and clinical practice. He also leads a specialist dual diagnosis clinic, addressing the complex needs of individuals with psychosis and substance misuse. Situated within the Psychosis Clinical Academic Group at the Department of Psychosis Studies, Professor Bhattacharyya’s work underscores a dedication to advancing psychiatric understanding and treatment.